A Polypeptide Linker for Preparing Multispecific Antibodies
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,958,913 | A Polypeptide Linker for Preparing Multispecific Antibodies In force · High confidence | Biomunex Pharmaceuticals | In force | High confidence | ||
| Application 18/589,695 | Polypeptide Linker for Preparing Multispecific Antibodies Pending Not granted | Biomunex Pharmaceuticals | Pending | Not granted |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Biomunex Pharmaceuticals.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.